rs1365924781
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032444.4(SLX4):c.5211G>T(p.Glu1737Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032444.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLX4 | NM_032444.4 | c.5211G>T | p.Glu1737Asp | missense_variant | 15/15 | ENST00000294008.4 | NP_115820.2 | |
SLX4 | XM_024450471.2 | c.5211G>T | p.Glu1737Asp | missense_variant | 15/15 | XP_024306239.1 | ||
SLX4 | XM_011522715.4 | c.5208G>T | p.Glu1736Asp | missense_variant | 15/15 | XP_011521017.1 | ||
SLX4 | XM_047434801.1 | c.4209G>T | p.Glu1403Asp | missense_variant | 11/11 | XP_047290757.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLX4 | ENST00000294008.4 | c.5211G>T | p.Glu1737Asp | missense_variant | 15/15 | 5 | NM_032444.4 | ENSP00000294008.3 | ||
ENSG00000261938 | ENST00000573982.1 | n.199-500C>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461136Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 726932
GnomAD4 genome Cov.: 33
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.